Jason K. Garland joined Repligen in September 2023 as the CFO, where he oversees financial operations for the Company, including all corporate finance and audit functions, capital markets and M&A transactions, financial planning and analysis, budgeting, financial risk management, information technology and investor relations.
Mr. Garland was previously with Integer Holdings Corporation, a medical device outsource manufacturer, where he served for nearly five years as Executive Vice President and CFO. Prior to Integer, he spent three years as Vice President and CFO for the global sales and supply divisions of Tiffany & Co., following nearly 20 years of increasing responsibility at General Electric Corporation, culminating in his role as CFO for GE Industrial Solutions, then a multi-billion dollar business with over 40 manufacturing sites.
Mr. Garland served on the board of directors and was Audit Committee Chair for Acutus Medical, a publicly-traded medical device company, from 2022 to 2025. He holds a B.S. in Chemical Engineering from the University of New Hampshire, and is Lean Six Sigma Black Belt certified.
Where the filing does not disclose a value, this page states "Not disclosed" rather than estimating. Smaller filers are exempt from disclosing metric targets and achievement, and larger filers may omit forward targets for competitive reasons.